Tranxene T-Tab is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Clorazepate Dipotassium.
| Product ID | 55292-304_1aad278c-14c5-4b8a-ad70-ce61a220936e |
| NDC | 55292-304 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tranxene T-Tab |
| Generic Name | Clorazepate Dipotassium |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1972-06-23 |
| Marketing End Date | 2023-01-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA017105 |
| Labeler Name | Recordati Rare Diseases, Inc. |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Active Ingredient Strength | 8 mg/1 |
| Pharm Classes | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Marketing Start Date | 1972-06-23 |
| Marketing End Date | 2023-01-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA017105 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1972-06-23 |
| Ingredient | Strength |
|---|---|
| CLORAZEPATE DIPOTASSIUM | 7.5 mg/1 |
| SPL SET ID: | 9c7ab45c-7461-6e4e-ee6d-f0ebe3eb4a28 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-0030 | Clorazepate Dipotassium | clorazepate dipotassium |
| 0378-0040 | Clorazepate Dipotassium | clorazepate dipotassium |
| 0378-0070 | Clorazepate Dipotassium | clorazepate dipotassium |
| 13107-319 | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM |
| 13107-320 | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM |
| 13107-321 | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM |
| 21695-433 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 21695-434 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 43063-030 | Clorazepate Dipotassium | clorazepate dipotassium |
| 43063-164 | Clorazepate Dipotassium | clorazepate dipotassium |
| 43063-350 | Clorazepate Dipotassium | clorazepate dipotassium |
| 43063-893 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 51672-4042 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 51672-4043 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 51672-4044 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 60505-4754 | Clorazepate Dipotassium | Clorazepate Dipotassium |
| 55292-304 | Tranxene | clorazepate dipotassium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRANXENE 72319593 0901420 Live/Registered |
ETABLISSEMENTS CLIN-BYLA 1969-02-19 |